Post Menopause Assessment Test Panel

About this test

This panel checks two key hormones to confirm and monitor menopausal status in women who have gone 12 or more consecutive months without a menstrual period. It's also useful for women on hormone replacement therapy (HRT) who want to check how their treatment is affecting hormone levels.

After menopause, estradiol levels remain very low and FSH remains consistently elevated. These two markers together confirm postmenopausal status and can serve as a baseline for monitoring women using estrogen therapy.

Components

• Estradiol (E2): The primary form of estrogen produced by the ovaries. After natural menopause, estradiol falls to very low levels (typically below 30 pg/mL). This baseline is useful for monitoring women starting hormone replacement therapy, as estradiol levels should rise appropriately with estrogen treatment.
• Follicle-Stimulating Hormone (FSH): Rises dramatically after menopause because the pituitary is no longer receiving feedback from functioning ovaries. A consistently elevated FSH — typically above 40 IU/L alongside low estradiol — confirms menopause. In women on HRT, FSH can help assess whether hormone levels are in an appropriate range.

Who is this test for?

This panel is appropriate for women who have completed menopause (no period for 12 consecutive months) and want to monitor the hormonal and metabolic changes that commonly accompany this life stage. Post-menopausal women are at increased risk for cardiovascular disease, osteoporosis, and thyroid dysfunction, and regular testing helps track these risks and guide preventive care.